We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
-18.19%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$13.6B
AUM Growth
+$1.76B
(+15%)
Cap. Flow
+$4.28B
Cap. Flow
% of AUM
31.58%
Top 10 Holdings %
Top 10 Hldgs %
12.23%
Holding
3,376
New
988
Increased
735
Reduced
602
Closed
941
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$170M |
| 2 |
Marathon Petroleum
MPC
|
+$162M |
| 3 |
Microsoft
MSFT
|
+$149M |
| 4 |
Chevron
CVX
|
+$147M |
| 5 |
Meta Platforms (Facebook)
META
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$100M |
| 2 |
Zoetis
ZTS
|
+$78.9M |
| 3 |
CERN
Cerner Corp
CERN
|
+$74M |
| 4 |
Sun Communities
SUI
|
+$68.8M |
| 5 |
Mondelez International
MDLZ
|
+$68.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.59% |
| 2 | Financials | 11.55% |
| 3 | Healthcare | 11.46% |
| 4 | Energy | 9.75% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Cardlytics
CDLX
$21.7M
| $541K | ﹤0.01% |
+2,424
| New | +$812K |
|
|
PLL
1377
DELISTED
Piedmont Lithium
PLL
| $541K | ﹤0.01% |
14,860
-2,948
| -17% | -$174K |
|
1378
Vanguard Global ex-US Real Estate ETF
VNQI
$3.49B
| $541K | ﹤0.01% |
12,225
-83,613
| -87% | -$3.99M |
|
1379
Credo Technology Group
CRDO
$37.6B
| $537K | ﹤0.01% |
+45,961
| New | +$534K |
|
1380
CleanSpark
CLSK
$3.56B
| $534K | ﹤0.01% |
+136,341
| New | +$917K |
|
1381
Vera Bradley
VRA
$105M
| $534K | ﹤0.01% |
+123,015
| New | +$751K |
|
1382
Vanguard World Funds Extended Duration ETF
EDV
$3.32B
| $532K | ﹤0.01% |
+5,318
| New | +$553K |
|
1383
Upbound Group
UPBD
$1.22B
| $532K | ﹤0.01% |
27,333
+121
| +0.4% | +$3.01K |
|
|
HTO
1384
H2O America
HTO
$2.65B
| $528K | ﹤0.01% |
8,455
-17,237
| -67% | -$1.07M |
|
1385
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.87B
| $527K | ﹤0.01% |
+10,533
| New | +$591K |
|
1386
Banco Bradesco
BBD
$38.4B
| $527K | ﹤0.01% |
+161,786
| New | +$622K |
|
1387
Avanos Medical
AVNS
$1.17B
| $525K | ﹤0.01% |
19,200
-9,408
| -33% | -$270K |
|
1388
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.08B
| $523K | ﹤0.01% |
19,368
| – | – |
|
1389
MacroGenics
MGNX
$248M
| $521K | ﹤0.01% |
176,710
+121,160
| +218% | +$637K |
|
|
LAZR
1390
DELISTED
Luminar Technologies
LAZR
| $518K | ﹤0.01% |
+5,826
| New | +$931K |
|
1391
Malibu Boats
MBUU
$552M
| $517K | ﹤0.01% |
+9,813
| New | +$533K |
|
1392
Ziff Davis
ZD
$1.95B
| $516K | ﹤0.01% |
6,929
-8,115
| -54% | -$673K |
|
1393
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
| $515K | ﹤0.01% |
+11,442
| New | +$554K |
|
1394
Ecovyst
ECVT
$1.33B
| $514K | ﹤0.01% |
+52,140
| New | +$542K |
|
1395
CareDx
CDNA
$1.89B
| $513K | ﹤0.01% |
23,860
+2,582
| +12% | +$71.6K |
|
1396
Adaptive Biotechnologies
ADPT
$3.51B
| $512K | ﹤0.01% |
63,340
+9,669
| +18% | +$85K |
|
1397
Interparfums
IPAR
$3.95B
| $512K | ﹤0.01% |
7,014
+1,276
| +22% | +$97.7K |
|
1398
IonQ
IONQ
$13B
| $511K | ﹤0.01% |
116,616
-3,516
| -3% | -$24.9K |
|
1399
Organogenesis Holdings
ORGO
$326M
| $511K | ﹤0.01% |
104,768
-4,592
| -4% | -$28.3K |
|
|
EGIO
1400
DELISTED
Edgio, Inc. Common Stock
EGIO
| $506K | ﹤0.01% |
+5,475
| New | +$788K |
|
Similar funds
Qube Research & Technologies (QRT)'s Q2 2022 Portfolio in Review
As of Q2 2022, Qube Research & Technologies (QRT) held 3,376 positions worth $13.6B, up 15% from $11.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Qube Research & Technologies (QRT) deployed $4.28B of net new capital in Q2 2022, opening 988 new positions and adding to 735 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 541,117 shares worth $148M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Verizon, an estimated $100M trimmed.
- Qube Research & Technologies (QRT)'s largest Q2 2022 buy was Berkshire Hathaway Class B: 541,117 shares worth $148M.
- Qube Research & Technologies (QRT) added most to Marathon Petroleum in Q2 2022, an estimated $162M increase.
- Qube Research & Technologies (QRT)'s biggest Q2 2022 reduction was Verizon, cutting an estimated $100M.
- Qube Research & Technologies (QRT) fully exited Cerner Corp in Q2 2022, selling an estimated $74M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 12% of its $13.6B portfolio in Q2 2022.
- Qube Research & Technologies (QRT) opened 988 new positions and closed 941 in Q2 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 15% quarter-over-quarter to $13.6B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2022, filed 15 Aug 2022.